Capillary rarefaction in treated and untreated hypertensive subjects. - Wikidata - awgldk - TriplyDB

Capillary rarefaction in treated and untreated hypertensive subjects.

Capillary rarefaction in treated and untreated hypertensive subjects.

http://www.wikidata.org/entity/Q37231033

about

The superoxide dismutase mimetic tempol does not alleviate glucocorticoid-mediated rarefaction of rat skeletal muscle capillaries.Alterations in capillary morphology are found in mild blood pressure elevation.Capillary rarefaction: an early marker of microvascular disease in young hemodialysis patients.Improvement in Retinal Capillary Rarefaction After Valsartan Treatment in Hypertensive Patients.Association of Adipokines with Insulin Resistance, Microvascular Dysfunction, and Endothelial Dysfunction in Healthy Young Adults Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus Non-invasive assessment of microvascular and endothelial function Bone marrow mononuclear cell angiogenic competency is suppressed by a high-salt diet.Retinal capillary rarefaction in patients with untreated mild-moderate hypertension.

P2860

Q33740881-6DE73464-192C-48A7-A50F-2CC15CEDC4A2 Q34204109-67611029-FA1C-4866-AE94-D49A1A004397 Q35310636-CFDBC7D1-1D17-4475-B745-28860D4841E7 Q36053490-EB230670-AB88-4D6F-9687-3330E3106B62 Q36208940-17152050-B305-447A-845F-AB0D323920B7 Q36217523-28BC95D3-FC50-443C-8FD2-A0BB35BCAADA Q36639580-4DFD1D79-D270-4CD4-AAB1-7DE8948121AB Q37575326-649A9492-FD38-4BF3-A90A-608C7C7FF1A7 Q47102389-BBA0553A-36A9-4266-977E-4B7119CE10B0

P2860

Capillary rarefaction in treated and untreated hypertensive subjects.

http://www.wikidata.org/entity/Q37231033

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Capillary rarefaction in treated and untreated hypertensive subjects.

@en

Capillary rarefaction in treated and untreated hypertensive subjects.

@nl

type

label

Capillary rarefaction in treated and untreated hypertensive subjects.

@en

Capillary rarefaction in treated and untreated hypertensive subjects.

@nl

prefLabel

Capillary rarefaction in treated and untreated hypertensive subjects.

@en

Capillary rarefaction in treated and untreated hypertensive subjects.

@nl

P1433

Q37231033-D3456860-5FF3-4CDF-8D62-4A4386B66BC5

P1476

Q37231033-7BD0C2D4-A7DD-4111-B380-F4382BA61E9D

P2093

Q37231033-641CC3C6-8835-4B7E-B9E4-87F76DDD4D0D

Q37231033-8637C579-83F0-455E-B38A-1B323C209980

Q37231033-AFAC10E5-2EF2-4490-80ED-E9F6D77BABE8

P2860

Q37231033-1396BD1E-B3D4-4147-A78A-C88A842764B4

Q37231033-1642BC1D-C6E8-4DBB-93A7-F0EC50A3CDBC

Q37231033-1D2C0940-3EBB-4EB2-89EB-B66F4EA5F001

Q37231033-25EE3143-FB0B-4CA4-9554-09C06F593773

Q37231033-299E13F5-AA6D-435E-8529-E7048330449D

Q37231033-2C86167D-1B36-4862-AB1C-E91A681BC0F1

Q37231033-2E6EF596-A0FD-4761-9F8C-B25C13808ABD

Q37231033-2FC58CB1-550D-4CA6-BFFF-041B6919DEBD

Q37231033-306F3533-0F1C-47C9-A38B-123C2F1ECE07

Q37231033-409BDD39-BCD6-4BBF-9416-453D89752379

P304

Q37231033-78829E44-B3BB-4E02-9219-883B77A5F2AC

P31

Q37231033-D5DE6E59-D0D4-4D5D-AC0A-53DF063D253E

P356

Q37231033-D3D1FBE8-6C3A-4242-854D-17BDC30AB49F

P433

Q37231033-AC01C97F-E3F3-4271-8C48-06DB1B570B1A

P478

Q37231033-8BFCA93A-E03E-4FB8-9EBA-4BE55DDF7198

P577

Q37231033-A892EF17-6E08-42EB-900C-B82FBFA43640

P5875

Q37231033-7B07DA3F-FE64-4546-91B2-D69655C9F3E4

P698

Q37231033-ECE0481E-7A3D-4C70-9F94-621D5C7C63A0

P932

Q37231033-EC863BF4-4889-43B5-B240-20D21A1717C3

P356

1753944708089696

P1433

Therapeutic advances in cardiovascular disease

P1476

Capillary rarefaction in treated and untreated hypertensive subjects.

@en

P2093

Bonita Falkner

http://www.w3.org/2001/XMLSchema#string

Constantine Daskalakis

http://www.w3.org/2001/XMLSchema#string

Cynthia Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure

Structural skin capillary rarefaction in essential hypertension.

Microvascular function relates to insulin sensitivity and blood pressure in normal subjects.

Testing for endothelial dysfunction.

Impact of high-normal blood pressure on the risk of cardiovascular disease.

Capillaroscopy and the measurement of capillary pressure

Early narrowed afferent arteriole is a contributor to the development of hypertension.

Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Prehypertension and cardiovascular morbidity.

Endothelial dysfunction: a marker of atherosclerotic risk.

P304

79-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1753944708089696

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23759453

http://www.w3.org/2001/XMLSchema#string

P698

19124411

http://www.w3.org/2001/XMLSchema#string

P932

2697846

http://www.w3.org/2001/XMLSchema#string